Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feghali

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Editorial: molecular insights into systemic sclerosis-associated interstitial lung diseaseRichard M Silver, Carol A Feghali-Bostwick
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena?Carol A Feghali-Bostwick, David S Wilkes
American Journal of Respiratory Cell and Molecular Biology|January 10, 2009
The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migrationHidekata Yasuoka, Yukie Yamaguchi, Carol A Feghali-Bostwick
Plos One|February 20, 2014
The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosisHidekata Yasuoka, Yukie Yamaguchi, Carol A Feghali-Bostwick
Critical Reviews in Eukaryotic Gene Expression|January 17, 2008
Gene expression in pulmonary fibrosisEileen Hsu, Hidekata Yasuoka, Carol A Feghali-Bostwick
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in sclerodermaC A Feghali, D W Boulware, L S Levy
Current Rheumatology Reports|April 29, 2010
Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung diseaseKristen L Veraldi, Eileen Hsu, Carol A Feghali-Bostwick
Arthritis and Rheumatism|September 1, 2007
B cell infiltration in systemic sclerosis-associated interstitial lung diseaseRobert Lafyatis, Carl O'Hara, Carol A Feghali-Bostwick, et al.
Current Opinion in Rheumatology|September 6, 2014
Update on scleroderma-associated interstitial lung diseaseMing-Hui Fan, Carol A Feghali-Bostwick, Richard M Silver
Plos One|November 28, 2012
Antifibrotic effects of roscovitine in normal and scleroderma fibroblastsRichard A Steinman, Andria Rasile Robinson, Carol A Feghali-Bostwick
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Editorial: molecular insights into systemic sclerosis-associated interstitial lung diseaseRichard M Silver, Carol A Feghali-Bostwick
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Autoimmunity in idiopathic pulmonary fibrosis: are circulating autoantibodies pathogenic or epiphenomena?Carol A Feghali-Bostwick, David S Wilkes
American Journal of Respiratory Cell and Molecular Biology|January 10, 2009
The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migrationHidekata Yasuoka, Yukie Yamaguchi, Carol A Feghali-Bostwick
Plos One|February 20, 2014
The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosisHidekata Yasuoka, Yukie Yamaguchi, Carol A Feghali-Bostwick
Critical Reviews in Eukaryotic Gene Expression|January 17, 2008
Gene expression in pulmonary fibrosisEileen Hsu, Hidekata Yasuoka, Carol A Feghali-Bostwick
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in sclerodermaC A Feghali, D W Boulware, L S Levy
Current Rheumatology Reports|April 29, 2010
Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung diseaseKristen L Veraldi, Eileen Hsu, Carol A Feghali-Bostwick
Arthritis and Rheumatism|September 1, 2007
B cell infiltration in systemic sclerosis-associated interstitial lung diseaseRobert Lafyatis, Carl O'Hara, Carol A Feghali-Bostwick, et al.
Current Opinion in Rheumatology|September 6, 2014
Update on scleroderma-associated interstitial lung diseaseMing-Hui Fan, Carol A Feghali-Bostwick, Richard M Silver
Plos One|November 28, 2012
Antifibrotic effects of roscovitine in normal and scleroderma fibroblastsRichard A Steinman, Andria Rasile Robinson, Carol A Feghali-Bostwick
Pageof 11